Pfizer–BioNTech COVID-19 vaccine

{{{Add text here}}}

Pfizer–BioNTech COVID-19 vaccine  (COVID-19 vaccine)
Interest of	Byram Bridle

COVID-19 vaccine

On 9 November 2020, Pfizer and partner BioNTech announced that their vaccine against COVID-19 was exceeding expectations. In a press conference Ben Osborn, Pfizer’s UK managing director, "refused to explain why the company needed an indemnity."

Pfizer CEO Albert Bourla instantly cashed in on the announcement, selling 60 percent of his Pfizer stock at $41.99, its highest level in more than a year. The sale had been arranged in advance under a so-called Rule 10b5-1 trading plan, which allows corporate executives to make predetermined stock transactions in compliance with insider trading laws. Bourla adopted the trading plan in August of this year.

Sally Susman, the company’s executive vice president and chief corporate affairs officer, dumped more than 43,000 shares to the tune of about $1.8 million. The sale was allegedly made under a Rule 10b5-1 plan Susman adopted in November 2019.

In December 2020, CEO Bourla said he and his management colleagues wouldn't take his company’s Covid-19 vaccine shot just yet, telling CNBC that he and other executives will not “cut the line.”

The vaccine was the first to be tested in the United States to generate late-stage data. The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo. For months, researchers have cautioned that a vaccine that might only be 60% or 70% effective.

The Phase 3 study is ongoing and additional data could affect results.

In keeping with guidance from the Food and Drug Administration, the companies will not file for an emergency use authorisation to distribute the vaccine until they reach another milestone: when half of the patients in their study have been observed for any safety issues for at least two months following their second dose. Pfizer expects to cross that threshold in the third week of November:

“I’ve been in vaccine development for 35 years,” said William Gruber, Pfizer’s senior vice president of vaccine clinical research and development. “I’ve seen some really good things. This is extraordinary.” He later added: “This really bodes well for us being able to get a handle on the epidemic and get us out of this situation.”

Approved for use

On 21 December 2020, following approval by the UK's MHRA and the US FDA, the European Medicines Agency (EMA) authorised the Pfizer BioNTech Covid-19 vaccine for the EU's nearly 448 million inhabitants. The EMA said the drug had demonstrated an efficacy of 95% and could be used in people aged 16 and over:

"Today's positive news is an important step forward in our fight against this pandemic, which has caused suffering and hardship for so many," said the EMA's executive director, Emer Cooke. "Our thorough evaluation means that we can confidently assure EU citizens of the safety and efficacy of this vaccine and that it meets necessary quality standards. However, our work does not stop here. We will continue to collect and analyse data on the safety and effectiveness of this vaccine to protect people taking the vaccine in the EU."

PfizerLeak

On 26th of July 2021, the cybersecurity researcher Ehden Biber started to publish the contract Pfizer has with Brazil and Albania online, using the hashtag #PfizerLeak on Twitter.

 

Related Quotations

Page	Quote	Author	Date
Albert Bourla	“Frederick Kempe: There was some fake news during this period of time about the vaccines, you know, all sorts of conspiracy theories. How did you deal with that and how did you navigate that and where do you feel the primary source of this sort of fake news was? How damaging was this to us? Albert Bourla: I’m afraid it [caused] quite a lot of damage and particularly with us, we were targeted by a lot of, let’s say, dark organizations that you don’t really know [who owns them]. You suspect that there are some countries behind. We were getting a lot of briefings from CIA, from FBI, about cyberattacks that may happen to us, but also about the spread of misinformation. You know, there are two groups of people: There are the people that they are vaccinated. There are people that are skeptical about the vaccination, and both of them are afraid. Those that are getting the vaccine, they are afraid of the disease, and they believe that because people are not getting vaccinated, they are increasing the risk to them. They are increasing the exposure. So they are mad with them that they don’t get the vaccine. Those that don’t get the vaccine, they’re afraid of the vaccine and they are mad with the people that are pressing them to get it. Those I understand. They are very good people. They are decent people. But they had a fear, and I understand it, and they don’t want to take chances. But there is a very small part of professionals [who] circulate, on purpose, misinformation so that they will mislead those that they have concerns [with the vaccine]. Those people are criminals. They’re not bad people. They are criminals because they literally cost millions of lives.”	Frederick Kempe Albert Bourla	9 November 2021
Albert Bourla	“The dynamics in the COVID more and more indicate a potential that we will have a clearly repeated business… Now we still don’t have data about the immunity of our vaccine because it is early. But we do see that the people that have the disease, more and more publications indicate that after several months, the immune response goes down. So there is a need to boost.””	Albert Bourla
Byram Bridle	“But this is because these COVID-19 vaccines have reached the public rollout phase by, and I’ll say it in quotes, “cutting corners”. And by cutting corners, I’m not implying that people were skipping key steps, although honestly, there could be some potential questions around that.”	Byram Bridle	24 February 2021
Byram Bridle	“None of us were expecting, I don’t think, that the vaccines would be rolled out very early on in the phase three clinical trials. So the phase three trials are not done. So in essence, what this means is the public rollout right now is an extension of the phase three clinical trial. So those being vaccinated now are, whether they realize it or not, part of the phase three experiment.”	Byram Bridle	24 February 2021
Byram Bridle	“We made a big mistake. We didn’t realize it until now... We thought the spike protein was a great target antigen... So by vaccinating people we are inadvertently inoculating them with a toxin.... We have known for a long time that the spike protein is a pathogenic protein. It is a toxin. It can cause damage in our body if it gets into circulation... Now, we have clear-cut evidence that the vaccines that make the cells in our deltoid muscles manufacture this protein — that the vaccine itself, plus the protein — gets into blood circulation.”	Byram Bridle	24 February 2021
Dolores Cahill	“Anyone who’s over 70 who gets one of these mRNA vaccines will probably sadly die within about two to three years.    And I would say anyone who gets the mRNA injection, no matter what age you are, your life expectancy will be reduced to, you know, die if you’re in your thirties within five to ten years, and you probably will have allergy, neuro-cognitive issues, inflammation, and of course infertility is the major one”	Dolores Cahill	May 2021
Lee Merritt	“Two months is not enough time to know that we won’t have that antibody enhancement problem,” Merritt said. “And I will make this military point: It’s the perfect binary weapon. There’s no way I know exactly what that mRNA is programmed to do and neither do you and neither do most doctors. The doctors can’t get that data. That rests with the guys at the very top of this project. They say it’s to the spiked protein but how do we prove it? So if I were China and I wanted to take down our military, that’s easy,” she continued. “I could hook onto this coronavirus, like the spiked protein or another protein, I just design an mRNA to do that, but I know it doesn’t exist in nature so nobody is going to die from the vaccine, and then two years later I release whatever it is I made, the counterpart, and it causes this immunity enhancement death. So it’s a time-delayed death. That’s what binary poisons are: I give you point one, and then later on you accidentally come in contact with point two and you die.”	Lee Merritt	January 2021
Michael Yeadon	“The toxicity of 1st generation vaccines is incidental & presumably is because they REQUIRE this gene based technology to execute their plans.”	Michael Yeadon	August 2021

 

Related Documents

Title	Type	Publication date	Author(s)	Description
Document:Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial	article	2 November 2021	Paul D Thacker	Whistleblowers from a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial say never experienced such a “helter skelter" work environment, saying speed may have come at the cost of data integrity and patient safety.
Document:Why are government experts holding off vaccinating under-16s in the UK?	Article	6 August 2021	Deepti Gurdasani	Pro COVID-19/Vaccine propaganda from an epidemiologist with ties to Big Pharma. The JCVI does not recommend jabs for under-16s and the approval process has slowed down. The rushed vaccination process is not rushed enough apparently.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.